Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kashuba

Showing results (241-250 of 555) with videos related to

Pageof 56
Sort By:
Acta Naturae|November 7, 2017
Expression Levels of the Uridine-Cytidine Kinase Like-1 Protein As a Novel Prognostic Factor for Hepatitis C Virus-Associated Hepatocellular CarcinomasA Buivydiene, V Liakina, J Valantinas, et al.
Clinical Pharmacology and Therapeutics|June 19, 1998
Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotypingA D Kashuba, J S Bertino, G L Kearns, et al.
FEBS Letters|June 17, 1999
Identification of new tumor suppressor genes based on in vivo functional inactivation of a candidate geneJ Li, A I Protopopov, R Z Gizatullin, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 9, 2020
A mechanism-based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID-19 treatment in humansPatrick O Hanafin, Brian Jermain, Anthony J Hickey, et al.
Plos One|July 11, 2013
Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platformTore Midtvedt, Eugene Zabarovsky, Elisabeth Norin, et al.
Clinical Pharmacology and Therapeutics|February 11, 2019
Contemporary Drug-Drug Interactions in HIV TreatmentAaron S Devanathan, Daijha J C Anderson, Mackenzie L Cottrell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 21, 2008
The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic Fatty liver disease and correlates with plasma caspase-3/7 activitySarah J Schrieber, Zhiming Wen, Manoli Vourvahis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2004
Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 inductionMichael L Lim, Sherene S Min, Joseph J Eron, et al.
Journal of the American Society for Mass Spectrometry|October 17, 2018
Evaluation of Digital Image Recognition Methods for Mass Spectrometry Imaging Data AnalysisMåns Ekelöf, Kenneth P Garrard, Rika Judd, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2025
Interlaboratory comparison of a dried blood spot assay for antiretroviral adherence: implications for clinical applicationNathan Engel, Craig Sykes, Amanda P Schauer, et al.
Pageof 56

Showing results (241-250 of 555) with videos related to

Sort By:
Pageof 56
Acta Naturae|November 7, 2017
Expression Levels of the Uridine-Cytidine Kinase Like-1 Protein As a Novel Prognostic Factor for Hepatitis C Virus-Associated Hepatocellular CarcinomasA Buivydiene, V Liakina, J Valantinas, et al.
Clinical Pharmacology and Therapeutics|June 19, 1998
Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotypingA D Kashuba, J S Bertino, G L Kearns, et al.
FEBS Letters|June 17, 1999
Identification of new tumor suppressor genes based on in vivo functional inactivation of a candidate geneJ Li, A I Protopopov, R Z Gizatullin, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 9, 2020
A mechanism-based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID-19 treatment in humansPatrick O Hanafin, Brian Jermain, Anthony J Hickey, et al.
Plos One|July 11, 2013
Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platformTore Midtvedt, Eugene Zabarovsky, Elisabeth Norin, et al.
Clinical Pharmacology and Therapeutics|February 11, 2019
Contemporary Drug-Drug Interactions in HIV TreatmentAaron S Devanathan, Daijha J C Anderson, Mackenzie L Cottrell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 21, 2008
The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic Fatty liver disease and correlates with plasma caspase-3/7 activitySarah J Schrieber, Zhiming Wen, Manoli Vourvahis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2004
Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 inductionMichael L Lim, Sherene S Min, Joseph J Eron, et al.
Journal of the American Society for Mass Spectrometry|October 17, 2018
Evaluation of Digital Image Recognition Methods for Mass Spectrometry Imaging Data AnalysisMåns Ekelöf, Kenneth P Garrard, Rika Judd, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2025
Interlaboratory comparison of a dried blood spot assay for antiretroviral adherence: implications for clinical applicationNathan Engel, Craig Sykes, Amanda P Schauer, et al.
Pageof 56